糖皮质激素受体激活重编程 NK 细胞以驱动 AREG 介导的免疫抑制:AREG 的泛癌作用
Glucocorticoid Receptor Activation Reprograms NK Cells to Drive AREG-Mediated Immunosuppression: A Pan-Cancer Role for AREG.
72.2分
★★★★☆
站内排序·非疗效
FRONTIER PAPERS
Glucocorticoid Receptor Activation Reprograms NK Cells to Drive AREG-Mediated Immunosuppression: A Pan-Cancer Role for AREG.
Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。